Physician profile
Thomas E Eng
NPI 1639277551
$2,053.46
in general payments reported to CMS, 2019-2025
7 companies · $501 in 2025
The $501 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $78.80 · 2021: $285 · 2023: $331 · 2024: $857 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,689.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $830.12 | 2021-2025 | Infinity, Infinity Adaptis, Augment Injectable |
| Treace Medical Concepts, INC. | $505.50 | 2024-2025 | |
| Solventum Corporation | $376.65 | 2024-2025 | Prevena, Activ.A.C., V.A.C. Veraflo |
| Acera Surgical, INC. | $152.55 | 2024 | Restrata Wound Matrix |
| Janssen Pharmaceuticals, INC | $91.56 | 2021 | |
| Medela LLC | $78.80 | 2020 | |
| Catalyst Pharmaceuticals, INC. | $18.28 | 2023 | Firdapse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Eng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.